$BRQL
brooqLy, Inc.

2024 Q2 Form 10-K Financial Statement

#000147793224001718 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $152.00 $0.00 $5.00
YoY Change 15100.0% -99.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $74.81K $67.28K $314.3K
YoY Change 115.9% 0.66%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.16K $9.760K $32.59K
YoY Change 102.67% 67.3%
% of Gross Profit
Operating Expenses $74.81K $67.28K $314.3K
YoY Change 115.9% 0.66%
Operating Profit -$74.66K -$314.3K
YoY Change 115.47% 0.98%
Interest Expense $145.7K -$2.440K $34.30K
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $50.00 $320.00
YoY Change 220.0%
Pretax Income -$596.3K -$69.67K -$348.3K
YoY Change 1620.92% 11.93%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$596.3K -$69.67K -$348.3K
YoY Change 1620.92% 11.93%
Net Earnings / Revenue -392313.16% -6965760.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 24.37M shares 24.23M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.00 $0.00 $0.00
YoY Change -99.53%
Cash & Equivalents $33.00 $2.00
Short-Term Investments
Other Short-Term Assets $30.20K $30.20K $30.20K
YoY Change 0.0% 15000.0%
Inventory
Prepaid Expenses $30.20K $30.20K
Receivables
Other Receivables
Total Short-Term Assets $30.24K $30.21K $30.21K
YoY Change -17.45% 14634.63% 14285.71%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $235.2K $171.1K
YoY Change 32.12%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $235.2K $171.1K $171.1K
YoY Change 105.18% 32.12% 32.12%
TOTAL ASSETS
Total Short-Term Assets $30.24K $30.21K $30.21K
Total Long-Term Assets $235.2K $171.1K $171.1K
Total Assets $265.4K $201.3K $201.3K
YoY Change 75.48% 55.2% 55.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $154.8K $145.1K $145.1K
YoY Change 188.87% 22.47% 22.47%
Accrued Expenses $115.2K $54.79K $54.79K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $65.00K $55.00K $55.00K
YoY Change 18.18%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $358.9K $278.2K $278.2K
YoY Change 173.14% 98.23% 98.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $358.9K $278.2K $278.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $358.9K $278.2K $278.2K
YoY Change 173.14% 98.22%
SHAREHOLDERS EQUITY
Retained Earnings -$1.521M -$828.8K
YoY Change 133.97% 72.49%
Common Stock $2.537K $2.424K
YoY Change 7.32% 7.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$93.52K -$76.96K -$76.96K
YoY Change
Total Liabilities & Shareholders Equity $265.4K $201.3K $201.3K
YoY Change 75.48% 55.2% 55.2%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$596.3K -$69.67K -$348.3K
YoY Change 1620.92% 11.93%
Depreciation, Depletion And Amortization $15.16K $9.760K $32.59K
YoY Change 102.67% 67.3%
Cash From Operating Activities $101.5K $49.04K -$80.83K
YoY Change -198.94% 185.33%
INVESTING ACTIVITIES
Capital Expenditures $32.44K $52.17K $74.17K
YoY Change -25.61%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$32.44K -$52.17K -$74.17K
YoY Change -25.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $100.0K
YoY Change 28.21%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -70.00K 0.000 $155.0K
YoY Change -193.33% 58.16%
NET CHANGE
Cash From Operating Activities 101.5K 49.04K -$80.83K
Cash From Investing Activities -32.44K -52.17K -$74.17K
Cash From Financing Activities -70.00K 0.000 $155.0K
Net Change In Cash -980.0 -3.130K $1.00
YoY Change -96.44% -100.0%
FREE CASH FLOW
Cash From Operating Activities $101.5K $49.04K -$80.83K
Capital Expenditures $32.44K $52.17K $74.17K
Free Cash Flow $69.02K -$3.130K -$155.0K
YoY Change -167.3% 21.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-311263 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-311160 usd
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
191446 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
312256 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
4303 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
749373 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001854526
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22584982 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24234982 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-56399
CY2023 dei Entity Registrant Name
EntityRegistrantName
BrooqLy, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2265420
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
10101 S. Robert Road
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 209
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Palos Hills
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60465
CY2023 dei City Area Code
CityAreaCode
718
CY2023 dei Local Phone Number
LocalPhoneNumber
705-8770
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24365000 shares
CY2023 dei Auditor Firm
AuditorFirmId
587
CY2023 dei Auditor Name
AuditorName
RBSM LLP
CY2023 dei Auditor Location
AuditorLocation
New York, NY
CY2023Q4 us-gaap Cash
Cash
2 usd
CY2023Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
55000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22584982 shares
CY2022Q4 brql Common Stock To Be Issued
CommonStockToBeIssued
20000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-480469 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10672 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129693 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
993 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
0 usd
CY2022 us-gaap Other Income
OtherIncome
103 usd
CY2022 us-gaap Interest Expense
InterestExpense
0 usd
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
103 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-311160 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 brql Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
CY2022 brql Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
CY2023 brql Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
23621489 shares
CY2022 brql Weighted Average Number Of Share Outstanding Basics And Diluted
WeightedAverageNumberOfShareOutstandingBasicsAndDiluted
22336023 shares
CY2022 us-gaap Profit Loss
ProfitLoss
-311160 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19480 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
144800 usd
CY2023 brql Shares Issued For Loan And Interest
SharesIssuedForLoanAndInterest
60000 usd
CY2022 brql Shares Issued For Loan And Interest
SharesIssuedForLoanAndInterest
0 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
97722 usd
CY2023 brql Increase Decrease In Payroll Payable
IncreaseDecreaseInPayrollPayable
50488 usd
CY2022 brql Increase Decrease In Payroll Payable
IncreaseDecreaseInPayrollPayable
0 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-30000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4303 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
1468 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
20831 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-80826 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28327 usd
CY2023 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
74173 usd
CY2022 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
99707 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74173 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99707 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
78000 usd
CY2023 brql Proceeds From Shares To Be Issued For Cash
ProceedsFromSharesToBeIssuedForCash
0 usd
CY2022 brql Proceeds From Shares To Be Issued For Cash
ProceedsFromSharesToBeIssuedForCash
20000 usd
CY2023 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
55000 usd
CY2022 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-30034 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30035 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
100000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10672 usd
CY2023 brql Shares Issued For Cash Value
SharesIssuedForCashValue
100000 usd
CY2023 brql Shares Issued For Services Amount
SharesIssuedForServicesAmount
122000 usd
CY2023 brql Shares Issued For Loan And Interest Amount
SharesIssuedForLoanAndInterestAmount
60000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-348288 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-76960 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57688 usd
CY2022 brql Shares Issued For Cash Value
SharesIssuedForCashValue
78000 usd
CY2022 brql Shares Issued For Services Amount
SharesIssuedForServicesAmount
144800 usd
CY2022 brql Shares To Be Issued
SharesToBeIssued
20000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-311160 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10672 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
CY2023 brql Description Of Correction Of Immaterial Misstatement
DescriptionOfCorrectionOfImmaterialMisstatement
Company became aware of an adjustment to correct an error in our previously issued financial statements regarding additional paid in capital and interest expense in the amount of $120,000
CY2021 brql Additional Paid In Capital And Interest Expense
AdditionalPaidInCapitalAndInterestExpense
120000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
120000 usd
CY2023 brql Revenue
Revenue
5 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53021 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20436 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
171076 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
128488 usd
CY2023 brql Estimated Finite Lived Useful Lives
EstimatedFiniteLivedUsefulLives
P5Y
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
44942 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
44819 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
41923 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
27198 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
12193 usd
CY2023Q4 us-gaap Postconfirmation Amortizable Intangible Assets
PostconfirmationAmortizableIntangibleAssets
171076 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32585 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19480 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24234982 shares
CY2022Q1 brql Cancellation Of Shares
CancellationOfShares
1000000 shares
CY2022Q1 brql Purchase Of Warrants During Period
PurchaseOfWarrantsDuringPeriod
1000000 shares
CY2022Q1 brql Purchase Of Shares During Period
PurchaseOfSharesDuringPeriod
1000000 shares
CY2022Q1 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.10
CY2022Q1 brql Desription Of Investment1
DesriptionOfInvestment1
The investment was in excess of $50,000 entitling the investor to receive shares and warrants at a reduced price instead of at $0.20 per share from those investors investing less than $50,000. The investor failed to pay $75,000 of the aggregate investment and the Company has determined that the investor will not receive the benefit of the $0.10 per share price and its shares shall be calculated on the basis of $0.20 per share, for which there is an adjusted number of common shares (and no warrants), of 125,000 shares for the cash proceeds of $25,000 that the company received from the investor.
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
550000 shares
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
78000 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
350000 shares
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
35000 usd
CY2022 brql Proceeds From Cash Received
ProceedsFromCashReceived
20000 usd
CY2022 brql Shares To Be Issued For Cash Proceeds
SharesToBeIssuedForCashProceeds
100000 shares
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
617482 shares
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
174295 usd
CY2023 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
550000 shares
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2023 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
600000 shares
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
122000 usd
CY2023 brql Shares To Be Issued For Cash Proceeds
SharesToBeIssuedForCashProceeds
100000 shares
CY2023 brql Proceeds From Cash Received
ProceedsFromCashReceived
20000 usd
CY2023 brql Issuance Of Common Stock Shares For The Conversion Loan
IssuanceOfCommonStockSharesForTheConversionLoan
500000 shares
CY2023 brql Issuance Of Common Stock Shares For The Conversion Loan Value
IssuanceOfCommonStockSharesForTheConversionLoanValue
60000 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
828757 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
480469 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
174040 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
100898 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
174040 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
100898 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd

Files In Submission

Name View Source Status
0001477932-24-001718-index-headers.html Edgar Link pending
0001477932-24-001718-index.html Edgar Link pending
0001477932-24-001718.txt Edgar Link pending
0001477932-24-001718-xbrl.zip Edgar Link pending
brooqly_10k.htm Edgar Link pending
brooqly_10kimg1.jpg Edgar Link pending
brooqly_ex311.htm Edgar Link pending
brooqly_ex312.htm Edgar Link pending
brooqly_ex321.htm Edgar Link pending
brooqly_ex322.htm Edgar Link pending
brql-20231231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
brql-20231231_def.xml Edgar Link unprocessable
brql-20231231_lab.xml Edgar Link unprocessable
brql-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brooqly_10k_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brql-20231231_cal.xml Edgar Link unprocessable